CN103773884B - 用于检测肺炎衣原体98KDa MOMP基因的引物组和探针及其应用 - Google Patents
用于检测肺炎衣原体98KDa MOMP基因的引物组和探针及其应用 Download PDFInfo
- Publication number
- CN103773884B CN103773884B CN201410049236.4A CN201410049236A CN103773884B CN 103773884 B CN103773884 B CN 103773884B CN 201410049236 A CN201410049236 A CN 201410049236A CN 103773884 B CN103773884 B CN 103773884B
- Authority
- CN
- China
- Prior art keywords
- nucleotide sequence
- probe
- seqidno
- test kit
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001647372 Chlamydia pneumoniae Species 0.000 title claims abstract description 275
- 239000000523 sample Substances 0.000 title claims abstract description 206
- 101710164702 Major outer membrane protein Proteins 0.000 title abstract description 11
- 101710105759 Major outer membrane porin Proteins 0.000 title abstract 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 89
- 239000002773 nucleotide Substances 0.000 claims abstract description 86
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 67
- 238000002360 preparation method Methods 0.000 claims abstract description 66
- 238000001514 detection method Methods 0.000 claims abstract description 51
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 41
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 17
- 230000003321 amplification Effects 0.000 claims description 192
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 192
- 238000012360 testing method Methods 0.000 claims description 163
- 238000000034 method Methods 0.000 claims description 42
- 108010006785 Taq Polymerase Proteins 0.000 claims description 37
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 15
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 14
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 14
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 14
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 14
- 239000012634 fragment Substances 0.000 claims description 13
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 9
- 239000012472 biological sample Substances 0.000 claims description 7
- 238000002203 pretreatment Methods 0.000 claims description 5
- 239000013558 reference substance Substances 0.000 claims description 3
- 125000006853 reporter group Chemical group 0.000 claims description 3
- 238000004020 luminiscence type Methods 0.000 claims description 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 4
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 claims 2
- 230000001131 transforming effect Effects 0.000 claims 1
- 238000003753 real-time PCR Methods 0.000 abstract description 32
- 239000000203 mixture Substances 0.000 abstract description 13
- 230000035945 sensitivity Effects 0.000 abstract description 10
- 239000000243 solution Substances 0.000 description 201
- 238000006243 chemical reaction Methods 0.000 description 191
- 239000013612 plasmid Substances 0.000 description 97
- 239000013642 negative control Substances 0.000 description 43
- 239000013641 positive control Substances 0.000 description 43
- 102000004190 Enzymes Human genes 0.000 description 36
- 108090000790 Enzymes Proteins 0.000 description 36
- 230000004087 circulation Effects 0.000 description 35
- 108020004414 DNA Proteins 0.000 description 33
- 102100037111 Uracil-DNA glycosylase Human genes 0.000 description 30
- 108020004707 nucleic acids Proteins 0.000 description 24
- 102000039446 nucleic acids Human genes 0.000 description 24
- 150000007523 nucleic acids Chemical class 0.000 description 24
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 23
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 23
- 238000002474 experimental method Methods 0.000 description 23
- 230000000052 comparative effect Effects 0.000 description 21
- 238000005138 cryopreservation Methods 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 239000007788 liquid Substances 0.000 description 20
- 230000001954 sterilising effect Effects 0.000 description 20
- 229910021642 ultra pure water Inorganic materials 0.000 description 20
- 239000012498 ultrapure water Substances 0.000 description 20
- 101710173835 Penton protein Proteins 0.000 description 19
- PEASFKSPITUZGT-UHFFFAOYSA-N N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopentanecarboxamide Chemical compound O=C(C1CCCC1)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1 PEASFKSPITUZGT-UHFFFAOYSA-N 0.000 description 15
- 238000007400 DNA extraction Methods 0.000 description 14
- 206010036790 Productive cough Diseases 0.000 description 14
- 239000012467 final product Substances 0.000 description 14
- 239000002872 contrast media Substances 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- 238000003908 quality control method Methods 0.000 description 13
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical group C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- 208000024794 sputum Diseases 0.000 description 11
- 210000003802 sputum Anatomy 0.000 description 11
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 238000010791 quenching Methods 0.000 description 9
- 230000000171 quenching effect Effects 0.000 description 9
- 210000002345 respiratory system Anatomy 0.000 description 9
- 239000000284 extract Substances 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 238000012408 PCR amplification Methods 0.000 description 7
- 206010035664 Pneumonia Diseases 0.000 description 7
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 238000011109 contamination Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 241001647378 Chlamydia psittaci Species 0.000 description 5
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 5
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- -1 LPS core polysaccharide Chemical class 0.000 description 4
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 4
- 206010057190 Respiratory tract infections Diseases 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 238000001921 nucleic acid quantification Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 241000589248 Legionella Species 0.000 description 3
- 208000007764 Legionnaires' Disease Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 239000012925 reference material Substances 0.000 description 3
- 238000004879 turbidimetry Methods 0.000 description 3
- BHNQPLPANNDEGL-UHFFFAOYSA-N 2-(4-octylphenoxy)ethanol Chemical compound CCCCCCCCC1=CC=C(OCCO)C=C1 BHNQPLPANNDEGL-UHFFFAOYSA-N 0.000 description 2
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- 241000606069 Chlamydiaceae Species 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940038705 chlamydia trachomatis Drugs 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001647373 Chlamydia abortus Species 0.000 description 1
- 201000005019 Chlamydia pneumonia Diseases 0.000 description 1
- 101000833080 Chlamydia pneumoniae 1,4-alpha-glucan branching enzyme GlgB Proteins 0.000 description 1
- 108020001738 DNA Glycosylase Proteins 0.000 description 1
- 102000028381 DNA glycosylase Human genes 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000007503 antigenic stimulation Effects 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000012520 frozen sample Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 208000030773 pneumonia caused by chlamydia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000003805 vibration mixing Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
组别 | 引物和探针组合 |
第一组 | 引物:引物组1;探针:CP-P |
第二组 | 引物:引物组1;探针:CP-p1 |
第三组 | 引物:引物组2;探针:CP-P |
第四组 | 引物:引物组2;探针:CP-p1 |
第五组 | 引物:引物组3;探针:CP-p2 |
组分 | 终浓度 |
10×PCR Buffer | 1× |
MgCl2 | 4.8mmol/L |
dNTP/dUTP Mixture | 200μmol/L |
BSA | 1mg/mL |
引物1 | 100nmol/L |
引物2 | 100nmol/L |
探针 | 50nmol/L |
Taq DNA酶 | 0.033U/μL |
UDG酶 | 0.0033U/μL |
模板 | 2.0μL |
灭菌超纯水 | 至30μL |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410049236.4A CN103773884B (zh) | 2014-02-12 | 2014-02-12 | 用于检测肺炎衣原体98KDa MOMP基因的引物组和探针及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410049236.4A CN103773884B (zh) | 2014-02-12 | 2014-02-12 | 用于检测肺炎衣原体98KDa MOMP基因的引物组和探针及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103773884A CN103773884A (zh) | 2014-05-07 |
CN103773884B true CN103773884B (zh) | 2016-04-20 |
Family
ID=50566640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410049236.4A Active CN103773884B (zh) | 2014-02-12 | 2014-02-12 | 用于检测肺炎衣原体98KDa MOMP基因的引物组和探针及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103773884B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105567802A (zh) * | 2015-12-07 | 2016-05-11 | 江苏和创生物科技有限公司 | 肺炎衣原体荧光pcr检测试剂盒 |
CN109735641A (zh) * | 2019-03-01 | 2019-05-10 | 苏州点晶生物科技有限公司 | 一种肺炎衣原体快速检测引物组、试剂盒 |
CN109913564B (zh) * | 2019-04-09 | 2024-01-09 | 深圳市儿童医院 | 一种用于检测肺炎衣原体的引物探针组合物、试剂盒及方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013049891A1 (en) * | 2011-10-04 | 2013-04-11 | Genera Biosystems Limited | Compositions and methods of detecting respiratory pathogens using nucleic acid probes and subsets of beads |
-
2014
- 2014-02-12 CN CN201410049236.4A patent/CN103773884B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013049891A1 (en) * | 2011-10-04 | 2013-04-11 | Genera Biosystems Limited | Compositions and methods of detecting respiratory pathogens using nucleic acid probes and subsets of beads |
Non-Patent Citations (2)
Title |
---|
evaluation of two real-time PCR chemistries for the detection of Chlamydophila pneumoniae in clinical specimens;Stephanie L. Mitchell et al;《molecular and cellular probes》;20090730;摘要、第309页右栏第3段-第310页右栏第1段 * |
Platinum Quantitative PCR SuperMix-UDG;invitrogen;《invitrogen》;20100511;全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN103773884A (zh) | 2014-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107630098A (zh) | 用于联合检测多种呼吸道细菌的荧光pcr检测体系、试剂盒及检测方法 | |
CN103060451B (zh) | 一种肺炎支原体mp检测试剂盒 | |
CN106434996A (zh) | 一种检测鲍曼不动杆菌dna的试剂盒及检测方法 | |
CN108624720A (zh) | Raa荧光法检测裂谷热病毒的引物探针组及试剂盒 | |
CN104059975B (zh) | 对普罗威登斯菌o3,o4,o8,o12,o13和o20特异的核苷酸及其应用 | |
CN107937580A (zh) | 泌尿生殖道微生物检测用的引物和探针、试剂盒及试剂盒的使用方法 | |
CN110373485A (zh) | 一种解脲脲原体、沙眼衣原体和淋球菌三联检试剂盒 | |
CN109234419A (zh) | 炭疽杆菌双重荧光定量pcr检测试剂盒及检测方法 | |
CN103773884B (zh) | 用于检测肺炎衣原体98KDa MOMP基因的引物组和探针及其应用 | |
CN101736078A (zh) | 一种核酸等温扩增检测结核分枝杆菌活菌的方法及试剂盒 | |
CN104745689A (zh) | 一种用于检测百日咳杆菌的引物、探针和试剂盒 | |
CN111088380A (zh) | 布鲁氏菌lf-rpa检测引物和探针及检测试剂盒 | |
CN103074428B (zh) | 一种结核分枝杆菌tb检测试剂盒 | |
CN105349661A (zh) | 一种沙眼衣原体/淋球菌核酸检测试剂盒 | |
CN100371461C (zh) | 猪附红细胞体pcr检测方法 | |
CN102154487A (zh) | 检测土拉弗朗西斯菌的试剂及复合探针荧光定量pcr检测土拉弗朗西斯菌的方法 | |
CN105063228B (zh) | 一种柱状黄杆菌的检测试剂盒及检测方法 | |
CN103993090A (zh) | 对普罗威登斯菌o31,o41,o42,o43和o50特异的核苷酸及其应用 | |
CN102146467A (zh) | 检测鼠疫耶尔森氏菌的试剂及荧光定量pcr检测鼠疫耶尔森氏菌的方法 | |
CN108504756A (zh) | 基于特异性序列的维氏气单胞菌检测引物、试剂盒、检测方法及其开发方法 | |
CN106701942A (zh) | 一种猪肺炎支原体的实时荧光pcr检测试剂盒及其用途 | |
CN105349660A (zh) | 一种沙眼衣原体/解脲脲原体核酸检测试剂盒 | |
CN204039404U (zh) | 肺炎衣原体检测试剂盒 | |
CN102154466B (zh) | 一种对脑膜炎奈瑟氏菌的its特异的核苷酸及其应用 | |
CN106521030A (zh) | 猪瘟病毒、牛病毒性腹泻病毒双重荧光定量rt‑pcr检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Primer group and probe for detecting chlamydia pneumoniae 98KDa MOMP genes and application thereof Effective date of registration: 20200313 Granted publication date: 20160420 Pledgee: Shenzhen hi tech investment small loan Co.,Ltd. Pledgor: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020980000702 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210924 Granted publication date: 20160420 Pledgee: Shenzhen hi tech investment small loan Co.,Ltd. Pledgor: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020980000702 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Primer set and probe for detecting 98kda MOMP gene of Chlamydia pneumoniae and its application Effective date of registration: 20210927 Granted publication date: 20160420 Pledgee: Shenzhen hi tech investment small loan Co.,Ltd. Pledgor: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021980009992 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230428 Granted publication date: 20160420 Pledgee: Shenzhen hi tech investment small loan Co.,Ltd. Pledgor: SHENZHEN KANGMEI BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021980009992 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |